GFACX
Price
$70.67
Change
-$0.30 (-0.42%)
Updated
Jul 15 closing price
Net Assets
324.19B
JARTX
Price
$54.17
Change
+$0.15 (+0.28%)
Updated
Jul 15 closing price
Net Assets
23.07B
Interact to see
Advertisement

GFACX vs JARTX

Header iconGFACX vs JARTX Comparison
Open Charts GFACX vs JARTXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.67
Change-$0.30 (-0.42%)
VolumeN/A
Net Assets324.19B
Janus Henderson Forty S
Price$54.17
Change+$0.15 (+0.28%)
VolumeN/A
Net Assets23.07B
GFACX vs JARTX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. JARTX commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and JARTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 324B vs. JARTX (23.1B). GFACX (0.00) and JARTX (0.00) have matching dividends . GFACX was incepted earlier than JARTX: GFACX (24 years) vs JARTX (28 years). GFACX (1.36) is less costly to investors than JARTX (1.01). JARTX is a more actively managed with annual turnover of: 36.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than JARTX: GFACX (250) vs JARTX (2500). GFACX annual gain was more profitable for investors over the last year : 7.43 vs. JARTX (3.65). GFACX return over 5 years is better than : 35.36 vs. JARTX (31.93).
GFACXJARTXGFACX / JARTX
Total Expense Ratio1.361.01135%
Annual Report Gross Expense Ratio1.361.01135%
Fund Existence24 years28 years-
Gain YTD10.83810.169107%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets324B23.1B1,403%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.433.65203%
Returns for 3 years51.3957.9889%
Returns for 5 years35.3631.93111%
Returns for 10 years62.6563.7598%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQ0.380.01
+3.93%
Equillium
TELA2.010.01
+0.50%
TELA Bio
LDOS160.21-3.46
-2.11%
Leidos Holdings
AUB31.97-1.36
-4.08%
Atlantic Union Bankshares Corp
AUTL2.49-0.16
-6.04%
Autolus Therapeutics plc